Well - Medidata is certainly a highly credible partner. It's an indication that Imugene are very serious about the management of their Clinical Trials data. This is a highly professional operation - not the penny dreadful the market seems to regard it as.
In the end it all comes down to results and whether those results are believable. Credibility is vital, and Imugene are taking the right steps to ensure their credibility.
Now - back to waiting, lol.
Dave
Phase 2 Trial Prep, page-4
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
-0.001(2.56%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.8¢ | 3.9¢ | 3.8¢ | $134.8K | 3.498M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 1738258 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 494405 | 4 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
